Gliquidone

DB01251ApprovedSmall molecule

Gliquidone is a sulfonylurea drug used in the management of diabetes mellitus type 2. It is an ATP-dependent K+ (KATP) channel blocker.

Chemical structure of Gliquidone
Mechanism
Curator reviewed
Primary indication
Used in the treatment of diabetes mellitus type 2.Curator reviewed · 1 structured indication
Formula / weight
C27H33N3O6S · 527.632 g/mol (avg)
Code names
ARDF-26

Resolves to

Structure
InChIKeyLLJFMFZYVVLQKT-UHFFFAOYSA-NSMILESCOC1=CC2=C(C=C1)C(C)(C)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C2=O

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,044Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
11ContraindicationsEach with its own population and attribute set
Sign in
16Marketed productsAcross 5 countries and 6 labellers
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Gliquidone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account